BioSpace News Archive

Mabwell, an innovative biopharmaceutical company with the entire value chain of the pharmaceutical industry, announced the clinical trial application of its self-developed 9MW3811 injection for idiopathic pulmonary fibrosis has been approved by the United States Food and Drug Administration.

Mitsubishi Tanabe Pharma America, Inc. announced the one-year launch anniversary of RADICAVA ORS® in the U.S. Since becoming available in June 2022, RADICAVA ORS has been used to treat over 5,300 people living with amyotrophic lateral sclerosis.

Theradaptive, a biopharmaceutical company breaking new ground in targeted regenerative therapeutics, announces that it has closed a $26 million Series A funding round to advance development of its targeted regenerative therapeutics.

DEXIS IOS Solutions is pleased to announce the expansion of its portfolio and ecosystem through new digital end-to-end workflows.

Gemina Laboratories Ltd. is pleased to announce the company’s attendance at the American Association of Clinical Chemistry Annual Scientific Meeting & Clinical Lab Expo running from Sunday, July 23rd, 2023 to Thursday, July 27th, 2023 in Anaheim, California.

Expanded indication would cover patients 12 years of age or younger, a population that comprises approximately one in three patients treated for hemophilia B in the United States

Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) (FSE: 954) (the “Company”), a clinical-stage biotechnology company developing therapeutics to treat addiction with a near-term focus on Alcohol Use Disorder (AUD)

PharmaCyte Biotech, Inc. announces the final results of its previously announced tender offer to acquire up to 7,750,000 million shares of the Company’s common stock, par value $0.001 per share, at a price of $3.25 per share in cash, less any applicable withholding taxes and without interest.

Oliva Therapeutics, LLC, a healthcare company focused on product commercialization, sales, marketing, distribution, and promotion, announced a long-term partnership with Rio Biopharmaceuticals, Inc., a subsidiary of the EMS S/A Pharma family of companies, for the exclusive North American supply and distribution rights to a multi-product portfolio.

Nikon Instruments Inc. is pleased to announce the development and launch of the “ECLIPSE Ui”, an integrated microscope-based viewing system designed for both in-person clinical and remote pathological observation.